|
Interferon alfa-2a
Product Approval Information - Licensing Action
Proper name: Interferon alfa-2a
Tradename: Roferon-A
Manufacturer: Hoffman-La Roche Inc, Nutley, New Jersey, License #0136
Indication for Use: Revised package insert to provide for an induction regimen of 6 MIU three times a week for 12 weeks followed by the standard regimen given for an additional 12-36 weeks
Approval Date: 11/17/99
Type of submission: Biologics license supplement
Approval Letter (PDF),
(Text)
Reviews (PDF)
Biostatistical
Clinical
Epidemiology
Last Updated: 3/5/2001
 Back
to Top 
Back to Index
Date created: March 15, 2001 |
